SLIT2 and neoplasm: Specifically, inhibition of the WNT/β-catenin pathway by Slit2/Robo signaling enhances the formation of β-catenin and E-cadherin complexes, increasing tumor cell adhesion and inhibiting tumor invasion and migration, thereby improving patient prognosis [86].